• Consensus Rating: Hold
  • Consensus Price Target: $13.83
  • Forecasted Upside: 45.46%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$9.51
▼ -0.02 (-0.21%)

This chart shows the closing price for TIC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Acuren Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TIC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TIC

Analyst Price Target is $13.83
▲ +45.46% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Acuren in the last 3 months. The average price target is $13.83, with a high forecast of $15.00 and a low forecast of $11.50. The average price target represents a 45.46% upside from the last price of $9.51.

This chart shows the closing price for TIC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Acuren. This rating has held steady since October 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2025Jefferies Financial GroupReiterated RatingBuy ➝ Buy$15.00
11/14/2025UBS GroupLower TargetNeutral ➝ Neutral$15.00 ➝ $11.50
10/9/2025Robert W. BairdInitiated CoverageNeutral$15.00
10/9/2025Baird R WUpgradeHold
8/28/2025Jefferies Financial GroupInitiated CoverageBuy
8/8/2025UBS GroupLower TargetNeutral ➝ Neutral$11.50 ➝ $11.00
5/16/2025UBS GroupLower TargetNeutral ➝ Neutral$12.00 ➝ $11.50
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2025
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/6/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2025
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2025
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/5/2025

Current Sentiment

  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Acuren logo
Acuren Corporation provides critical asset integrity services in North America. Its activities include various nondestructive testing (NDT) solutions, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. Its NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid accidents, and comply with regulatory requirements without destroying the asset or component. The company also provides market rope access technician solutions, including inspection and testing, as well as insulation, coatings and blasting, welding, pipe fitting, hoisting and rigging, and electrical services. In addition, its TIC service includes support from consulting engineers with in-lab destructive testing capabilities. The company provides support failure investigation, material selection, corrosion engineering, welding engineering, fracture mechanics, destructive testing, and chemical analysis. It serves a range of industrial markets, primarily chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company was founded in 1991 and is headquartered in Tomball, Texas.
Read More

Today's Range

Now: $9.51
Low: $9.30
High: $9.51

50 Day Range

MA: $11.60
Low: $8.97
High: $14.49

52 Week Range

Now: $9.51
Low: $8.76
High: $14.94

Volume

1,686,448 shs

Average Volume

1,753,618 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Acuren?

The following sell-side analysts have issued stock ratings on Acuren in the last year: Baird R W, Jefferies Financial Group Inc., Robert W. Baird, and UBS Group AG.
View the latest analyst ratings for TIC.

What is the current price target for Acuren?

0 Wall Street analysts have set twelve-month price targets for Acuren in the last year. Their average twelve-month price target is $13.83, suggesting a possible upside of 45.5%. Robert W. Baird has the highest price target set, predicting TIC will reach $15.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $11.50 for Acuren in the next year.
View the latest price targets for TIC.

What is the current consensus analyst rating for Acuren?

Acuren currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TIC, but not buy more shares or sell existing shares.
View the latest ratings for TIC.

What other companies compete with Acuren?

How do I contact Acuren's investor relations team?

Acuren's physical mailing address is 14434 MEDICAL COMPLEX DRIVE, #100, TOMBALL, TX, 77377. The company's listed phone number is (800) 218-7450. The official website for Acuren is www.acuren.com. Learn More about contacing Acuren investor relations.